<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">about one month ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260922878704/en/EADV-2026-Galderma-to-Unveil-New-Data-Advancing-Understanding-of-Skin-Diseases-Skin-Longevity-and-Real-world-Patient-Experiences/">EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences</a>
    </div>

      <div class="me-0 me-md-5">
        ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Reuters</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">about 2 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.reuters.com/business/healthcare-pharmaceuticals/galderma-mindful-focus-while-eyeing-product-range-expansion-ceo-tells-fuw-2026-09-18/">Galderma mindful of focus while eyeing product range expansion, CEO tells FuW</a>
    </div>

      <div class="me-0 me-md-5">
        Galderma&#39;s CEO said the Swiss skincare firm plans to expand its ​product range at some point but ‌would remain cautious not to lose its focus, speaking in an interview with Swiss ​newspaper Finanz und Wirtschaft published on ​Friday.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">about 2 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260915734207/en/Galderma%E2%80%99s-Restylane%C2%AE-Volyme%E2%84%A2-Demonstrates-High-Effectiveness-Satisfaction-and-a-Robust-Safety-Profile-in-Chinese-Patients-With-Temple-Hollowing/">Galderma&#39;s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing</a>
    </div>

      <div class="me-0 me-md-5">
        ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.1 The study met its primary endpoint, demonstrating the effectiveness and safety of Restylane Volyme versus a no-treatment control, while also achieving high patient and investigator s...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Market Watch</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">2 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.marketwatch.com/story/plastic-surgery-is-booming-with-boomers-heres-how-to-cash-in-on-the-antiaging-craze-7f1ea891">Plastic surgery is booming with boomers. Here&#39;s how to cash in on the antiaging craze.</a>
    </div>

      <div class="me-0 me-md-5">
        Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">3 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260810880899/en/Galderma-Receives-European-Union-Approval-for-Restylane%C2%AE-Shaype%E2%84%A2-the-First-and-Only-Bone-Mimicking-Hyaluronic-Acid-Injectable-for-Facial-Shaping/">Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping</a>
    </div>

      <div class="me-0 me-md-5">
        ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection to build and shape on bone, Restylane Shaype delivers a unique bone-mimicking effect, enabling immediate, natural-looking structural enhancement in the lower face...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 news-box__source-badge">
          <img class="news-box__source-logo" alt="StocksGuide" src="https://stocksguide.com/assets/logos/stocks_guide-94bb1add.svg" />
        </div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a data-turbo-frame="_top" href="https://stocksguide.com/en/stock/Galderma-CH1335392721#earnings-events-section">Galderma Q2 2026 Earnings Call Transcript and Presentation available</a>
    </div>

      <a data-controller="earnings-news-cta" data-earnings-news-cta-event-id-value="4422952" data-action="click-&gt;earnings-news-cta#open" data-turbo-frame="_top" class="btn btn-outline-primary btn--small border-0 mt-0 px-2" href="https://stocksguide.com/en/stock/Galderma-CH1335392721?earnings_event_id=4422952">
        Show summary
        <i class="fa fa-arrow-right fa-fw"></i>
</a>  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
      <a data-turbo-frame="_top" href="https://stocksguide.com/en/stock/Galderma-CH1335392721#earnings-events-section">
        <div class="news-box__logo-frame mb-3 mb-md-0">
          <img class="news-box__logo" alt="Galderma" src="https://stocksguide.com/rails/active_storage/blobs/proxy/eyJfcmFpbHMiOnsiZGF0YSI6MjA2MzIsInB1ciI6ImJsb2JfaWQifX0=--b6520ac5e966ce141cfd81d0c49a4813c5164c94/Galderma-CH1335392721.png" />
          <span class="news-box__logo-label">Earnings Call Transcript</span>
        </div>
</a>  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">CNBC</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.cnbc.com/2026/07/23/botox-galderma-ozempic-face-glp1.html">Botox maker Galderma sees early boost from &#39;Ozempic face&#39; trend as GLP-1 use climbs, CEO says</a>
    </div>

      <div class="me-0 me-md-5">
        The increasing rate of patients using GLP-1 medications is now boosting growth in Galderma&#39;s aesthetics portfolio, CEO Flemming Ørnskov told CNBC on Thursday. About 10% of U.S. adults now report taking GLP-1 drugs for weight loss, which may boost demand for treatments like fillers and anti-wrinkle injections.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Galderma-CH1335392721">Galderma</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">4 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260722555754/en/Galderma-Reports-Record-First-Half-2026-Net-Sales-of-3.134-Billion-USD-and-24.6-Year-on-Year-Growth-at-Constant-Currency-Raises-Net-Sales-Guidance-for-the-Full-Year/">Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year</a>
    </div>

      <div class="me-0 me-md-5">
        ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2026. Net sales reached 3.134 billion USD, surpassing 3 billion USD for the first time in the first six months of the year and representing net sales growth of 24.6% at constant currency1. Broad-based, double-digit growth in bot...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/en/news/Galderma-CH1335392721/load_more?page=3">
      Show more News
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>